Abbott Laboratories
Revenue Breakdown
| Fiscal Year | Established Pharmaceutical Products | Nutritional Products | Diagnostic Products | Vascular Products | Medical Devices | Other |
|---|---|---|---|---|---|---|
| FY2016 | $3.86B | $6.90B | $4.81B | $2.90B | — | $2.39B |
| FY2017 | $4.29B | $6.93B | $5.62B | — | $10.33B | $237.0M |
| FY2018 | $4.42B | $7.23B | $7.50B | — | $11.37B | $62.0M |
| FY2019 | $4.49B | $7.41B | $7.71B | — | $12.24B | $57.0M |
| FY2020 | $4.30B | $7.65B | $10.81B | — | $11.79B | $66.0M |
| FY2021 | $4.72B | $8.29B | $15.64B | — | $14.37B | $52.0M |
| FY2022 | $4.91B | $7.46B | $16.58B | — | $14.69B | $11.0M |
| FY2023 | $5.07B | $8.15B | $9.99B | — | $16.89B | $14.0M |
| FY2024 | $5.19B | $8.41B | $9.34B | — | $18.99B | $16.0M |
| FY2025 | $5.54B | $8.45B | $8.94B | — | $21.39B | $17.0M |